Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Transcenta Holding Limited ( (HK:6628) ) just unveiled an update.
Transcenta Holding Limited has granted 2,000,000 award shares, equivalent to about 0.44% of its issued share capital (excluding treasury shares), to a single employee participant under its share incentive scheme. Half of the award is tied to the achievement of product development milestones and half to a four-year time-based vesting schedule, with all shares subject to a minimum 12‑month vesting period and detailed clawback provisions linked to employment status and conduct, underscoring the company’s efforts to align executive incentives with long-term performance and shareholder interests.
The most recent analyst rating on (HK:6628) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Transcenta Holding Limited stock, see the HK:6628 Stock Forecast page.
More about Transcenta Holding Limited
Transcenta Holding Limited is a Cayman Islands–registered company listed on the Hong Kong Stock Exchange, operating in the biopharmaceutical sector with a focus on product development. The company uses equity-based incentives, including share awards, to attract, retain and motivate key employees involved in advancing its pipeline and achieving development milestones.
Average Trading Volume: 1,324,700
Technical Sentiment Signal: Sell
Current Market Cap: HK$959.7M
See more insights into 6628 stock on TipRanks’ Stock Analysis page.